Pancreatic Cancer Research

ResearcherJilin UniversityNo recent work listed

Rui Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9886-949X; OpenAlex author ID A5100448401. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. 5-fluorouracil suppresses stem cell-like properties by inhibiting p38 in pancreatic cancer cell line PANC-1. Co-author DOI 10.5603/fhc.a2022.0004↗
  2. CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s13277-015-3819-y↗
  3. The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer. Co-author DOI 10.3109/09537104.2013.827782↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cuixia Cao · 1 shared paper, 2022 · strength 0.19
  2. Jin Zhao · 1 shared paper, 2022 · strength 0.19
  3. Xueying Shi · 1 shared paper, 2022 · strength 0.19
  4. Baofeng Xu · 1 shared paper, 2016 · strength 0.08
  5. Kexin Li · 1 shared paper, 2016 · strength 0.08
  6. Ting Deng · 1 shared paper, 2014 · strength 0.04
  7. Haiyan Wang · 1 shared paper, 2014 · strength 0.04
  8. Yi Ba · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.